TEST:

PredicineALERT™

PredicineALERT™ provides a generalized approach to MRD testing – an assay without the requirement for personalized individual probe designs, but instead utilizes methylation profiling. PredicineALERT™ MRD assay include: tumor-naive MRD detection without the need of personalization; fast turn-around-time (TAT) down to 6 days; sample input using as low as 2.5ng cell-free DNA